OrganoClick
ORGANOCLICK AB (PUBL) PUBLISH YEAR END REPORT FOR 2024
Translation from CEO Mårten Hellbergs comments to the Interim Report.
Q4, 1 October - 31 December 2024
The Group's result in Q4 2024 compared with Q4 2023
» Net revenue amounted to SEK 21.43 (27.91) million
» The gross margin amounted to 12.7 (18.4) %
» EBIT amounted to SEK -6.88 (-6.13) million
» Cash-flow from operating activities amounted to SEK 4.70 (6.66) million
1 January – 31 December 2024
The Group compared with 2023
» Net revenue amounted to SEK 127.23 (145.87) million
» The gross margin amounted to 25.0 (24.3) %
» EBIT amounted to SEK -9.86 (-9.23) million
» Cash-flow from operating activities amounted to SEK 3.60 (0.53) million
This disclosure contains information that OrganoClick AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 13-02-2025 08:30 CET.
| Datum | 2025-02-13, kl 08:30 |
| Källa | Cision |
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.